Back to Journals » OncoTargets and Therapy » Volume 6

Interleukin-12 prevents colorectal cancer liver metastases in mice

Authors Shen F, Li J, Cai W, Zhu G, Gu W, Jia L, Xu B

Received 18 February 2013

Accepted for publication 8 April 2013

Published 13 May 2013 Volume 2013:6 Pages 523—526

DOI https://doi.org/10.2147/OTT.S44161

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Download Article [PDF] 

Fei Shen, Jiang-Lin Li, Weng-Song Cai, Guang-Hui Zhu, Wei-Li Gu, Lin Jia, Bo Xu

Department of General Surgery, Guangzhou First People's Hospital, Guangzhou Medical College, Guangzhou, People's Republic of China

Abstract: Interleukin (IL)-12 has emerged to be a prospective molecule for antitumor therapies with many types of cancers. Here we examine the effect of IL-12 treatment in preventing the colorectal cancer liver metastasis in a mice model. At different doses, we found that IL-12 treatment decreased the formation of liver metastasis sites and the percentage of metastasis volume in the liver. Additionally, this treatment leads to improved survival function of mice after tumor cell transplantation. We believe that IL-12 based therapy provided a novel treatment to colorectal cancer patients suffering from liver metastasis.

Keywords: IL-12, liver metastasis, colorectal cancer, therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]